Polypeptides and uses thereof for treatment of autoimmune disorders and infection
US9428574B2 · kind B2 · utility
0Cited by
152References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2012 |
| Grant date | Aug 30, 2016 |
| Priority date | — |
| Expiry date | Oct 3, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to C1ORF32 protein and its variants and fragments and fusion proteins thereof, pharmaceutical composition comprising same and methods of use thereof for treatment of immune related disorders and infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.